Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:48 AM
Ignite Modification Date:
2025-12-24 @ 11:48 AM
NCT ID:
NCT05450861
Eligibility Criteria:
Inclusion Criteria:
* Patients within 20\~75 years old.
* Diagnosed with alopecia by dermatologists.
* Willing to maintain the same hair style, color, shampoo and hair products used, and approximate hair length starting from signing ICF and throughout the study.
* The subject can understand and obey order.
Exclusion Criteria:
* Pregnant, nursing, or planning a pregnancy during the study.
* Use of any topical medication (such as minoxidil or any other solution for hair growth), laser therapy, or chemotherapy, within the preceding 4 weeks.
* Personal medical history of abnormal blood clotting such as bleeding disorders or platelet dysfunction syndrome.
* Personal medical history of unstable vital signs such as hypotension or uncontrolled hypertension syndrome.
* Prior hair transplant.
* Chronic scalp disorders that require medications.
* Uses medication known to cause hair thinning such as Coumadin and anti- depressants/anti-psychotics.
* Existing scalp diseases such as folliculitis, scalp psoriasis, seborrheic dermatitis, or inflammatory scalp conditions.
* Enrolled in any other medical study or has been enrolled in any medical study in the past 6 months.
* Any hematologic abnormalities.
* Severe allergies manifested by a history of anaphylaxis, or history or presence of multiple severe allergies.
* Planned upcoming surgeries.
* Tattoo on scalp.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
75 Years
Study:
NCT05450861
Study Brief:
Protocol Section:
NCT05450861